Submitted by Anonymous (not verified) on 13 October 2023 - 10:12
Human medicines European public assessment report (EPAR): Xevudy, sotrovimab, COVID-19 virus infection, Date of authorisation: 17/12/2021, Revision: 11, Status: Authorised
Source: